Allred Capital Management, LLC Immuno Gen, Inc. Transaction History

Allred Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$5.79 - $8.6 $3,306 - $4,910	-571 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$6.5 - $10.53 $351 - $568	-54 Reduced 8.64%	571 $4,000
Q1 2020 Apr 17, 2020	BUY	$2.12 - $6.8 $16 - $54	8 Added 1.3%	625 $2.13 Million
Q4 2019 Jan 13, 2020	BUY	$2.25 - $5.8 $1,388 - $3,578	617 New	617 $3,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Allred Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Allred Capital Management, LLC with notifications on news.